<DOC>
	<DOC>NCT02265016</DOC>
	<brief_summary>The aim of this study is measurement of expression and activity of RBC eNOS in different clinical cohorts of patients with coronary artery disease and acute coronary syndrome and to investigate the importance of the NO-stimulated reaction cascade in terms of sGC and PKG.</brief_summary>
	<brief_title>Regulation and Signaling of Red Blood Cell (RBC) Endothelial Nitric Oxide Synthase (eNOS) in Patients With Stable and Unstable Coronary Artery Disease</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>informed consent for ACS(acute coronary syndrome)Group: angiographic coronary artery disease; acute coronary syndrome, defined by EITHER unstable angina pectoris with significant coronary stenosis (troponin negative, without significant STelevation) OR lowrisk NSTEMI (Troponin positive, without significant STelevation) for stable CADGroup: angiographic coronary artery disease; no acute coronary syndrome within the last 3 months healthy control group: No clinical or angiographical signs of apparent atherosclerosis acute inflammation (CRP &gt; 1 mg/dl, leukocyte &gt; 11.000/Âµl) malignant diseases pregnancy medication with NOdonors ( e.g.isosorbide mononitrate, isosorbide dinitrate, glyceryl trinitrate, Molsidomin, Ranexa) patients with STEMI or highrisk NSTEMI</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>coronary artery disease</keyword>
	<keyword>acute coronary syndrome</keyword>
	<keyword>angina pectoris</keyword>
	<keyword>non-ST-segment elevation myocardial infarction</keyword>
	<keyword>red blood cells</keyword>
	<keyword>erythrocytes</keyword>
</DOC>